Lipid implants for controlled release of biotec drugs
The invention is a lipid based implant, produced by screw extrusion. To achieve good extrudability, very homogeneous drug distribution, excellent mechanical strength, sustained release kinetics with a low burst and mainly stable modification of lipids an inventive lipid mixture has to be applied. The mixture is composed of at least 2 lipids, one of them being a high melting, solid lipid and the other a low melting point lipid. Thereby the lipid mixture can contain low
melting lipids in the form of solid, semisold or liquid lipids at room temperature. After adding the drug with a special procedure the mixture is formed into a solid implant by screw extrusion.
Further Information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
Contact
Peer Biskup
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Machine learning algorithm reveals long-theorized glass phase in crystal
Scientists have found evidence of an elusive, glassy phase of matter that emerges when a crystal’s perfect internal pattern is disrupted. X-ray technology and machine learning converge to shed light…
Mapping plant functional diversity from space
HKU ecologists revolutionize ecosystem monitoring with novel field-satellite integration. An international team of researchers, led by Professor Jin WU from the School of Biological Sciences at The University of Hong…
Inverters with constant full load capability
…enable an increase in the performance of electric drives. Overheating components significantly limit the performance of drivetrains in electric vehicles. Inverters in particular are subject to a high thermal load,…
